Previous 10 | Next 10 |
Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference PR Newswire SAN DIEGO , May 5, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engi...
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting PR Newswire SAN DIEGO , April 27, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietar...
Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences PR Newswire SAN DIEGO , April 8, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering plat...
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board PR Newswire SAN DIEGO , March 23, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing propriet...
PSTX is an early-stage CAR-T and gene therapy developer. Lead asset is targeting multiple myeloma and has early-stage data. The company is well-capitalized and may become interesting in the future. For further details see: Poseida: Early Stage CAR-T And Gene Therapy Deve...
Poseida Therapeutics (PSTX): Q4 GAAP EPS of -$0.58 beats by $0.11.As of December 31, 2020, cash, cash equivalents and marketable securities were $309.2MPress Release For further details see: Poseida Therapeutics EPS beats by $0.11
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 PR Newswire SAN DIEGO , March 11, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizin...
Shares of Poseida Therapeutics (NASDAQ:PSTX) were jumping 21.2% higher as of 12:08 p.m. EST on Wednesday. The big gain came with the company providing a pipeline update at its virtual R&D Day today. Poseida said that its virtual R&D Day will include a presentation of a case ...
Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor (OMI) +32%, Salarius Pharmaceuticals (SLRX) +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences (PRAH) +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals (CNST)...
Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day Virtual R&D Day featuring key opinion leaders and Poseida's scientific team members to be hel...
News, Short Squeeze, Breakout and More Instantly...
Poseida Therapeutics Inc. Company Name:
PSTX Stock Symbol:
NASDAQ Market:
Poseida Therapeutics Inc. Website:
Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advanci...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders PR Newswire SAN DIEGO , June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differ...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 PR Newswire Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeti...